220 related articles for article (PubMed ID: 25216752)
1. Alteration of splice site selection in the LMNA gene and inhibition of progerin production via AMPK activation.
Finley J
Med Hypotheses; 2014 Nov; 83(5):580-7. PubMed ID: 25216752
[TBL] [Abstract][Full Text] [Related]
2. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of latently infected HIV-1 viral reservoirs and correction of aberrant alternative splicing in the LMNA gene via AMPK activation: Common mechanism of action linking HIV-1 latency and Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2015 Sep; 85(3):320-32. PubMed ID: 26115946
[TBL] [Abstract][Full Text] [Related]
4. A conserved splicing mechanism of the LMNA gene controls premature aging.
Lopez-Mejia IC; Vautrot V; De Toledo M; Behm-Ansmant I; Bourgeois CF; Navarro CL; Osorio FG; Freije JM; Stévenin J; De Sandre-Giovannoli A; Lopez-Otin C; Lévy N; Branlant C; Tazi J
Hum Mol Genet; 2011 Dec; 20(23):4540-55. PubMed ID: 21875900
[TBL] [Abstract][Full Text] [Related]
5. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
Moulson CL; Fong LG; Gardner JM; Farber EA; Go G; Passariello A; Grange DK; Young SG; Miner JH
Hum Mutat; 2007 Sep; 28(9):882-9. PubMed ID: 17469202
[TBL] [Abstract][Full Text] [Related]
6. Interplay of primary sequence, position and secondary RNA structure determines alternative splicing of LMNA in a pre-mature aging syndrome.
Shilo A; Tosto FA; Rausch JW; Le Grice SFJ; Misteli T
Nucleic Acids Res; 2019 Jun; 47(11):5922-5935. PubMed ID: 31006814
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel RNA isoforms of LMNA.
DeBoy E; Puttaraju M; Jailwala P; Kasoji M; Cam M; Misteli T
Nucleus; 2017 Sep; 8(5):573-582. PubMed ID: 28857661
[TBL] [Abstract][Full Text] [Related]
8. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
[TBL] [Abstract][Full Text] [Related]
9. [Hutchinson-Gilford progeria in the light of contemporary genetics].
Madej-Pilarczyk A
Med Wieku Rozwoj; 2006; 10(1 Pt 2):355-62. PubMed ID: 17028399
[TBL] [Abstract][Full Text] [Related]
10. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
12. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
13. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
14. Splicing-directed therapy in a new mouse model of human accelerated aging.
Osorio FG; Navarro CL; Cadiñanos J; López-Mejía IC; Quirós PM; Bartoli C; Rivera J; Tazi J; Guzmán G; Varela I; Depetris D; de Carlos F; Cobo J; Andrés V; De Sandre-Giovannoli A; Freije JM; Lévy N; López-Otín C
Sci Transl Med; 2011 Oct; 3(106):106ra107. PubMed ID: 22030750
[TBL] [Abstract][Full Text] [Related]
15. Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.
Luo YB; Mitrpant C; Johnsen RD; Fabian VA; Fletcher S; Mastaglia FL; Wilton SD
Int J Clin Exp Pathol; 2013; 6(12):2778-86. PubMed ID: 24294364
[TBL] [Abstract][Full Text] [Related]
16. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
[TBL] [Abstract][Full Text] [Related]
17. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides.
Fong LG; Vickers TA; Farber EA; Choi C; Yun UJ; Hu Y; Yang SH; Coffinier C; Lee R; Yin L; Davies BS; Andres DA; Spielmann HP; Bennett CF; Young SG
Hum Mol Genet; 2009 Jul; 18(13):2462-71. PubMed ID: 19376814
[TBL] [Abstract][Full Text] [Related]
18. Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn.
Reunert J; Wentzell R; Walter M; Jakubiczka S; Zenker M; Brune T; Rust S; Marquardt T
Eur J Hum Genet; 2012 Sep; 20(9):933-7. PubMed ID: 22419169
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy.
Messner M; Ghadge SK; Goetsch V; Wimmer A; Dörler J; Pölzl G; Zaruba MM
PLoS One; 2018; 13(4):e0196739. PubMed ID: 29702688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
